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Background: Genome-wide association studies (GWAS) have had recent success in revealing genetic associations for common diseases such as 
hypertension. To determine single-nucleotide polymorphisms (SNPs) that may be implicated in the development and regulation of hypertension in 
Hispanics, we have performed a GWAS of hypertension involving 998 patients.
Methods: Patients were ascertained from Miami Cardiovascular Registry and approximately 60% were of Hispanic origin. Data were generated 
using the Affymetrix SNP array 6.0 platform for 900,000 SNPs. Standard quality controls tests were performed. We tested for association using 
linear regression using the PLINK software package, and included age, gender, number of medications and two variables describing the population 
substructure.
Results: There were strong associations (p<0.00001) detected for systolic blood pressure (SBP), at 7 SNPs on 4 different chromosomes, in 5 
genes. SNPs rs1930767 and rs1171386 were located on chromosome 1 in the FAM5C gene, associated with myocardial infarction. The strongest 
association for SBP was SNP rs837398 (p-value 5.57x10-7) on chromosome 1, on gene CYP4B1, which encodes a cytochrome P450 enzyme 
involved in lipid synthesis.
For the diastolic blood pressure endpoint, there were associations at 14 SNPs (p<0.0001), on 4 different chromosomes. A group of SNPs on 
chromosome 12 (p<0.000001) were located on gene CMKLR1, associated with obesity and metabolic syndrome. The strongest association was 
found at SNP rs7611752 on chromosome 3, in gene IGF2BP2. This gene has been implicated as susceptibility loci for development of diabetes 
mellitus.
Conclusion: Genome-wide association studies have been promising in revealing SNPs related to the development and regulation of hypertension. 
Our study is the first to analyze a predominately Hispanic population. In a comparison of SNPs from prior multi-cohort studies to those in this 
analysis, exact matches were found. Also, several SNPs were located in or around genes that contribute to co-morbidities of hypertension including 
diabetes, dyslipidemia, obesity, and myocardial infarction. An additional 1,000 samples are being investigated to confirm our findings.
